Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002920001 | SCV003655455 | uncertain significance | Inborn genetic diseases | 2022-10-26 | criteria provided, single submitter | clinical testing | The c.1088T>G (p.L363R) alteration is located in exon 9 (coding exon 9) of the B3GALNT2 gene. This alteration results from a T to G substitution at nucleotide position 1088, causing the leucine (L) at amino acid position 363 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003143554 | SCV003829691 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 | 2019-04-02 | criteria provided, single submitter | clinical testing |